Biohaven (BHVN) Retained Earnings (2022 - 2026)
Biohaven (BHVN) reported Retained Earnings of -$2.2 billion for Q1 2026, down 41.32% on a YoY basis from -$3.8 billion in Q1 2025, and down 1241.88% sequentially from $194.0 million in Q4 2025.
Biohaven (BHVN) Retained Earnings (2022 - 2026) Analysis & Trends
Biohaven (BHVN) has 5 years of Retained Earnings data on file, last reported at -$2.2 billion in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 41.32% year-over-year to -$2.2 billion; the trailing twelve-month figure through Mar 2026 stood at -$2.2 billion (down 41.32% YoY), and the FY2025 full-year result was $194.0 million, up 114.41% from the prior year.
- Retained Earnings slipped to -$2.2 billion in Q1 2026, from $194.0 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $194.0 million in Q4 2025 to a low of -$2.2 billion in Q1 2026.
- A 5-year average of -$520.4 million and a median of $101000.0 in 2023 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings plunged 175907.04% in 2023 and jumped 41698.19% in 2024, its largest moves.
- Tracing BHVN's Retained Earnings over 5 years: stood at $284000.0 in 2022, then sank by 175907.04% to -$499.3 million in 2023, then tumbled by 169.52% to -$1.3 billion in 2024, then surged by 114.41% to $194.0 million in 2025, then tumbled by 1241.88% to -$2.2 billion in 2026.
- Business Quant data shows BHVN's Retained Earnings at -$2.2 billion in Q1 2026, $194.0 million in Q4 2025, and $36000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Biohaven | 2.16 Bn | 1.81 Bn | - | -2.22 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.22 Bn |
| Dec 31, 2025 | 193.98 Mn |
| Sep 30, 2025 | 36,000.00 |
| Jun 30, 2025 | -1.77 Bn |
| Mar 31, 2025 | -1.57 Bn |
| Dec 31, 2024 | -1.35 Bn |
| Sep 30, 2024 | 93.04 Mn |
| Jun 30, 2024 | 83.83 Mn |
| Mar 31, 2024 | 69.39 Mn |
| Dec 31, 2023 | -499.29 Mn |
| Sep 30, 2023 | -354.54 Mn |
| Jun 30, 2023 | 21.69 Mn |
| Mar 31, 2023 | 166,000.00 |
| Dec 31, 2022 | 284,000.00 |